SLV-2436 5 mg | 99.85%
TargetMol
SLV-2436 (SEL201-88) is a novel effective and ATP-competitive inhibitor of MNK1 and MNK2 (IC50: 10.8/5.4 nM).
More Information Supplier PageSLV-2436
Search Results
Posaconazole 100 mg | Purity Not Available
TargetMol
Posaconazole
AZD 6482 1 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
EPZ015666 1 mg | 99.29%
TargetMol
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity.
More Information Supplier PageEPZ015666
Triciribine 100 mg | 100.00%
TargetMol
Triciribine is a DNA synthesis inhibitor, and it also inhibits Akt and HIV-1/2.
More Information Supplier PageTriciribine
LY2886721 100 mg | 99.94%
TargetMol
LY2886721, a BACE inhibitor, is used for the therapy of Alzheimer’s Disease.
More Information Supplier PageLY2886721
SLV-2436 25 mg | 99.85%
TargetMol
SLV-2436 (SEL201-88) is a novel effective and ATP-competitive inhibitor of MNK1 and MNK2 (IC50: 10.8/5.4 nM).
More Information Supplier PageSLV-2436
SLV-2436 10 mg | 99.85%
TargetMol
SLV-2436 (SEL201-88) is a novel effective and ATP-competitive inhibitor of MNK1 and MNK2 (IC50: 10.8/5.4 nM).
More Information Supplier PageSLV-2436
Lificiguat 100 mg | 99.48%
TargetMol
YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).
More Information Supplier PageLificiguat
Lificiguat 50 mg | 99.48%
TargetMol
YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).
More Information Supplier PageLificiguat